40
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Incidence of coronary artery lesions in children with recurrent Kawasaki disease

, , , , , , , ORCID Icon & show all
Pages 673-678 | Received 27 Nov 2023, Accepted 29 Jan 2024, Published online: 07 Feb 2024

References

  • Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004;364(9433):533–44. doi: 10.1016/S0140-6736(04)16814-1
  • Matsubara T, Ichiyama T, Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol. 2005;141(3):381–387. doi: 10.1111/j.1365-2249.2005.02821.x
  • Chang LY, Lu CY, Shao PL, et al. Viral infections associated with Kawasaki disease. J Formosan Med Assoc. 2014;113(3):148–154. doi: 10.1016/j.jfma.2013.12.008
  • Sudo D, Nakamura Y. Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years. Acta Paediatr. 2017;106(5):796–800. doi: 10.1111/apa.13773
  • Sudo D, Makino N, Nakamura Y. Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan. Arch Dis Child. 2020;105(9):848–852. doi: 10.1136/archdischild-2019-317238
  • Kim GB, Han JW, Park YW, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J. 2014;33(1):24–27. doi: 10.1097/INF.0000000000000010
  • Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015;57(6):1116–1120. doi: 10.1111/ped.12733
  • Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. Pediatr Int. 2012;54(3):383–387. doi: 10.1111/j.1442-200X.2012.03628.x
  • Rowley AH. Multisystem inflammatory syndrome in children and Kawasaki Disease: two different illnesses with overlapping clinical features. J Pediatr. 2020;224:129–132. doi: 10.1016/j.jpeds.2020.06.057
  • Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100(11):1084–1088. doi: 10.1136/archdischild-2014-307536
  • Hua W, Ma F, Wang Y, et al. A new scoring system to predict Kawasaki disease with coronary artery lesions. Clin Rheumatol. 2019;38(4):1099–1107. doi: 10.1007/s10067-018-4393-7
  • Liu J, Yuan P, Pang Y, et al. ITPKC polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population. Front Immunol. 2023;14:1184162. doi: 10.3389/fimmu.2023.1184162
  • Xie LP, Yan WL, Huang M, et al. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017. J Epidemiol. 2020;30(10):429–35. doi: 10.2188/jea.JE20190065
  • Makino N, Nakamura Y, Yashiro M, et al. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016. Pediatr Int. 2019;61(4):397–403. doi: 10.1111/ped.13809
  • Kim GB, Park S, Eun LY, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014. Pediatr Infect Dis J. 2017;36(5):482–485. doi: 10.1097/INF.0000000000001474
  • Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, endocarditis and Kawasaki disease, Council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110(17):2747–2771. doi: 10.1161/01.CIR.0000145143.19711.78
  • Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001;90(1):40–4. doi: 10.1080/080352501750064851
  • Guleria S, Pilania RK, Jindal AK, et al. Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience. Int J Rheum Dis. 2019;22(7):1183–7. doi: 10.1111/1756-185X.13519
  • Kim SY, Shin JS, Jang MS, et al. Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up. Arch Dis Child. 2023;108(4):307–312. doi: 10.1136/archdischild-2022-324467
  • Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012;22(3):216–221. doi: 10.2188/jea.je20110126
  • Ae R, Makino N, Kosami K, et al. Epidemiology, treatments, and cardiac complications in patients with Kawasaki Disease: the nationwide survey in Japan, 2017-2018. J Pediatr. 2020;225:23–9.e2. doi: 10.1016/j.jpeds.2020.05.034
  • Luo G, Pan S-L, Wang S-B, et al. Clinical features of children with recurrent Kawasaki disease: a Meta analysis. Zhongguo dang dai er ke za zhi =. Chin J Contemp Pediatr. 2020;22(12):1306–1312. doi: 10.7499/j.issn.1008-8830.2009138
  • Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr. 2013;172(12):1641–1647. doi: 10.1007/s00431-013-2101-9
  • Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics. 2009;123(3):e401–5. doi: 10.1542/peds.2008-2187
  • Masuda H, Ae R, Koshimizu TA, et al. Epidemiology and risk factors for giant coronary artery aneurysms identified after acute Kawasaki disease. Pediatr Cardiol. 2021;42(4):969–77. doi: 10.1007/s00246-021-02571-8
  • Kobayashi T, Fuse S, Sakamoto N, et al. A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J Am Soc Echocardiogr. 2016;29(8):794–801.e29. doi: 10.1016/j.echo.2016.03.017
  • Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011;24(1):60–74. doi: 10.1016/j.echo.2010.10.004
  • Ae R, Maddox RA, Abrams JY, et al. Kawasaki disease with coronary artery lesions detected at initial echocardiography. J Am Heart Assoc. 2021;10(7):e019853. doi: 10.1161/JAHA.120.019853
  • Duan J, Jiang H, Lu M. Risk factors for coronary artery lesions in children with Kawasaki disease. Arch Argent Pediatr. 2020;118(5):327–31. doi: 10.5546/aap.2020.eng.327

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.